Related Experiment Video
Updated: Jul 10, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
ST/HR slope during prostacyclin treatment: an improved method to identify patients with advanced coronary artery
R Bugiardini1, A Borghi, G Morgagni
1Institute of Patologia Medica, University of Bologna, Italy.
Insights
Iloprost improved the accuracy of the ST/HR slope test in diagnosing coronary artery disease severity. This prostacyclin analogue enhanced coronary flow reserve, particularly in patients with less severe atherosclerosis.
Area of Science:
- Cardiology
- Clinical Medicine
- Pharmacology
Background:
- Exercise-induced coronary artery constriction can reduce coronary flow reserve.
- This constriction may limit the accuracy of the ST/HR slope in assessing coronary artery disease severity.
Purpose of the Study:
- To evaluate the effect of iloprost-induced coronary vasodilation on the diagnostic accuracy of the ST/HR slope.
- To compare ST/HR slopes during placebo versus iloprost administration in patients with coronary artery disease.
Main Methods:
- 42 patients with angina and coronary artery disease underwent exercise testing with ST/HR slope analysis.
- Tests were performed with placebo and during infusion of iloprost (a prostacyclin analogue).
- A subset of patients (n=7) underwent repeat testing during right heart catheterization.
Main Results:
- Iloprost improved the overall diagnostic accuracy of the ST/HR slope compared to placebo, especially in advanced coronary artery disease.
- A rightward shift in the ST/HR slope was observed with iloprost in one- and two-vessel disease, but not in three-vessel or left main stem disease.
- Higher coronary blood flow during iloprost infusion suggests prevention of dynamic coronary events, potentially benefiting patients with minor atherosclerosis.
Conclusions:
- Iloprost enhances the diagnostic utility of the ST/HR slope for coronary artery disease severity.
- The drug's benefits appear more pronounced in patients with less advanced atherosclerotic disease.
- Iloprost may mitigate exercise-induced reductions in coronary flow reserve through prevention of dynamic coronary events.
Abstract:
Constriction of atherosclerotic coronary segments during exercise may further reduce coronary flow reserve in patients with coronary artery disease. This could influence the linear regression analysis of the heart rate-related changes in ST-segment depression (ST/HR slope) thereby limiting the accuracy of this method in identifying the severity of the disease. To test this hypothesis, the exercise related ST/HR slopes on placebo were compared with those obtained during coronary vasodilation induced by a prostacyclin analogue (iloprost 6 ng kg-1 min-1) in 42 anginal patients with documented coronary artery disease. In seven of these, the same protocol was repeated during right heart catheterization. The overall diagnostic accuracy of the ST/HR slope on iloprost was better than on placebo in patients with advanced coronary artery disease. This was due mainly to a consistent rightward shift of the ST/HR slope in patients with one- and two-vessel, but not three-vessel disease or left main stem disease. The reason for the greater effects of iloprost on ST/HR slopes in patients with a lesser degree of atherosclerosis remains unclear. However, coronary blood flow was higher during drug infusion, which suggests that iloprost may prevent the occurrence of dynamic coronary events able to reduce the maximum coronary flow reserve during exertion. This mechanism may be predominant in patients with minor coronary artery disease.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

